A number of firms have modified their ratings and price targets on shares of Universal Health Services (NYSE: UHS) recently:
- 5/2/2026 – Universal Health Services was downgraded by Wall Street Zen from “buy” to “hold”.
- 4/30/2026 – Universal Health Services had its price target lowered by UBS Group AG from $320.00 to $310.00. They now have a “buy” rating on the stock.
- 4/29/2026 – Universal Health Services had its price target lowered by Cantor Fitzgerald from $229.00 to $194.00. They now have a “neutral” rating on the stock.
- 4/29/2026 – Universal Health Services had its price target lowered by Guggenheim from $238.00 to $211.00. They now have a “buy” rating on the stock.
- 4/29/2026 – Universal Health Services was downgraded by Raymond James Financial, Inc. from “outperform” to “market perform”.
- 4/29/2026 – Universal Health Services had its price target lowered by Stephens from $235.00 to $205.00. They now have an “equal weight” rating on the stock.
- 4/29/2026 – Universal Health Services had its price target lowered by Morgan Stanley from $233.00 to $212.00. They now have an “equal weight” rating on the stock.
- 4/29/2026 – Universal Health Services had its price target lowered by Mizuho from $267.00 to $230.00. They now have an “outperform” rating on the stock.
- 4/29/2026 – Universal Health Services had its price target lowered by TD Cowen from $245.00 to $230.00. They now have a “buy” rating on the stock.
- 4/29/2026 – Universal Health Services had its price target lowered by Deutsche Bank Aktiengesellschaft from $261.00 to $230.00. They now have a “buy” rating on the stock.
- 4/29/2026 – Universal Health Services had its price target lowered by Royal Bank Of Canada from $216.00 to $190.00. They now have a “sector perform” rating on the stock.
- 4/29/2026 – Universal Health Services had its price target lowered by Robert W. Baird from $241.00 to $204.00. They now have a “neutral” rating on the stock.
- 4/28/2026 – Universal Health Services had its price target lowered by Barclays PLC from $268.00 to $238.00. They now have an “overweight” rating on the stock.
- 4/17/2026 – Universal Health Services was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
- 4/13/2026 – Universal Health Services had its price target lowered by Guggenheim from $262.00 to $238.00. They now have a “buy” rating on the stock.
- 4/12/2026 – Universal Health Services was upgraded by Wall Street Zen from “hold” to “buy”.
- 4/4/2026 – Universal Health Services was downgraded by Wall Street Zen from “buy” to “hold”.
Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.
In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.
See Also
- Five stocks we like better than Universal Health Services
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Universal Health Services Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services Inc and related companies with MarketBeat.com's FREE daily email newsletter.
